Enhancing tumor specific immune responses by transcutaneous vaccination

Enhancing tumor specific immune responses by transcutaneous vaccination

Introduction: Our understanding of the involvement of the immune system in cancer control has increased over recent years. However, the development of cancer vaccines intended to reverse tumor-induced immune tolerance remains slow as most current vaccine candidates exhibit limited clinical efficacy....

Full description

Bibliographic Details
Main Authors: Hanadi Saliba, Béatrice Heurtault, Hasnaa Bouharoun-Tayoun, Vincent Flacher, Benoît Frisch, Sylvie Fournel, Soulaima Chamat
Format: Article
Language:English
Published: Taylor & Francis Group 2017-11-01
Series:Expert Review of Vaccines
Subjects:
cancer vaccine
liposome
nanoparticle
skin dendritic cell
transcutaneous vaccination
Online Access:http://dx.doi.org/10.1080/14760584.2017.1382357

Similar Items

Similar Items